Market Overview of Publicly Traded Cannabis Companies Across U.S., Canadian, and Australian Exchanges

KR L PI L AC EL CA TA CHAPTER VII Capital Markets for Cannabis Companies the NYSE are two of the largest and most recognized stock exchanges in the world, with stringent listing, trading and corporate governance requirements. Conversely, the OTC has much less stringent requirements; as a result, most publicly traded cannabis-related companies are traded on the OTC. In Canada, cannabis-related companies are traded on the Toronto Stock Exchange (TSX), the TSX Venture Exchange (TSXV), which is an affiliate of the TSX, and the Canadian Securities Exchange (CSE). The TSX is one of the world’s largest stock exchanges and, similar to Nasdaq and the NYSE, has stringent listing, trading and corporate governance requirements. The TSXV focuses on companies with small market capitalization and has less stringent listing requirements than the TSX. The CSE is focused on micro capitalization and emerging growth companies, and it has the least stringent listing requirements of the primary Canadian exchanges. In order to be listed on either the TSX or the TSXV, a company is required to be in compliance with Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) and all applicable laws in jurisdictions within which it operates. (Operations of listed companies are restricted in jurisdictions, such as the United States, where cannabis is federally prohibited.) Unlike the TSX and TSXV, the CSE has allowed companies listed on its exchange to invest in, acquire and otherwise operate cannabis-related businesses in the United States. The following table provides a summary of the cannabis-related companies traded on U.S., Cana- dian and Australian stock markets. As stated previously, many cannabis-related companies are traded on more than one market to attract additional investors and facilitate trading in multiple jurisdictions. For example, most companies traded on the Canadian markets are also traded on the OTC. Summary of Publicly Traded Cannabis-Related Companies (As of November 30, 2017) Average ($U.S. millions) Number of Market Enterprise LTM LTM Companies Value Value Cash Debt Revenue EBITDA Nasdaq 4 —$1,033.6 $884.5 $153.6 $4.5 $44.0 -$81.1 NYSE 1 63.5 41.3 22.2 0.0 46 -1.2 NYSE American Z 152.1 145.7 78 1.4 Us -6.5 OTC 212 46.3 65.5 5.7 25.0 14.0 0.2 United States 219 $65.5 $81.2 $8.5 $24.3 $14.5 -$1.4 Toronto Stock Exchange (TSX) 6 $1,361.5 $1,311.4 $71.0 $20.8 $26.6 $0.8 TSX Venture Exchange (TSXV) 20 131.5 123.9 10.8 33 1.2 -3.5 Canadian Securities Exchange (CSE) Af 12.6 72.0 2.0 1.4 1.8 -2.8 Canada 67 $210.6 $203.3 $11.1 $3.8 $4.0 -$2.2 Australian Securities Exchange (ASX) 14 $85.3 $80.1 $5.9 $0.7 $0.9 -$2.1 Australia 14 $85.3 $80.1 $5.9 $07 $0.9 -$2.1 Source: S&P Global Market Intelligence. Companies that are traded on more than one market are included in their primary market as determined by S&P Global Market Intelligence, based on stock price history, trading volume and availability of estimates. Enterprise Value is defined as Market Value plus Debt minus Cash and Cash Equivalents. LTM is Last Twelve Months. EBITDA is defined as Earnings Before Interest, Taxes, Depreciation and Amortization. © 2017 Ackrell Capital, LLC | Member FINRA/SIPC 119 HOUSE_OVERSIGHT_024755